An Overview of Low Vision Devices and Technology by Dan Roberts Updated 1/21/2020 Can a blind person see? Most thoughtful people now understand, or can be led to understand, that a blind person can indeed “see”. Just not with the eyes. Modern science has shown that it is our brains that see by interpreting the light signals [Read More]
News
A Fish Tale
by Ellen Troyer, MT, MA CEO, Biosyntrx While Biosyntrx supports a limited amount of omega-3 fatty acid EPA and DHA intake from fish or fish oil, we believe it’s important to discuss the growing amount of science that questions excessive fish oil intake. Hypothesis Vs. Outcome An April 14, 2014, meta-analysis-accepted manuscript in the Canadian [Read More]
Stem Cell Trial Progressing
StemCells, Inc. announced that it has transplanted purified human neural stem cells (HuCNS-SC®) into the first five of eight patients in the final cohort of its 16-patient Phase I/II trial for dry AMD. The trial is currently enrolling patients at five centers at: Retina Foundation of the Southwest, Dallas, TX (214) 363-3911 Byers Eye Institute [Read More]
Summary of Research and Developments, 2013-2014
by Dan Roberts This has been a year of watching and waiting, as many studies and clinical trials are bearing down on promising treatments and cures for retinal diseases. My ninth annual report will offer brief descriptions of the work done in pharmaceutical treatments, anti-VEGF and combination therapies for neovascularization, stem cell therapy, gene therapy, [Read More]
Experimental Therapies for CSR
by Dan Roberts April 2014 Updated August 18, 2018 Research has shown that corticosteroids produced by the body (endogenous) and administered externally (exogenous) can raise adrenaline levels, which can harm the central retina. Some people have high levels of endogenous steroids that can lead to a condition called central serous retinopathy (CSR), aka central serous [Read More]